Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Brivudine in the Treatment of Herpes Zoster: A Multicenter, Randomized, Prospective Clinical Trial

NCT07099157 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT07099157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07099157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Brivudine in the Treatment of Herpes Zoster: A Multicenter, Randomized, Prospective Clinical Trial
Lead sponsor
Peking University Third Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
August 25, 2025
Completion date
December 31, 2027
Enrollment
140 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

herpes zoster